• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Validation of an asthma quality of life diary in a clinical trial.一项临床试验中哮喘生活质量日记的验证
Thorax. 1995 Jul;50(7):724-30. doi: 10.1136/thx.50.7.724.
2
Comparison of salmeterol with beclomethasone in adult patients with mild persistent asthma who are already on low-dose inhaled steroids.沙美特罗与倍氯米松在已接受低剂量吸入性类固醇治疗的轻度持续性哮喘成年患者中的比较。
J Asthma. 1999;36(1):97-106. doi: 10.3109/02770909909065153.
3
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.在使用现有吸入性糖皮质激素仍有症状的哮喘患者中,加用沙美特罗与高剂量糖皮质激素的比较。英国艾伦汉伯里有限公司研究小组。
Lancet. 1994 Jul 23;344(8917):219-24. doi: 10.1016/s0140-6736(94)92996-3.
4
Salmeterol added to inhaled corticosteroid therapy is superior to doubling the dose of inhaled corticosteroids: a randomized clinical trial.沙美特罗加吸入性糖皮质激素治疗优于加倍吸入性糖皮质激素剂量:一项随机临床试验。
J Asthma. 1999 Dec;36(8):703-15. doi: 10.3109/02770909909055422.
5
Salmeterol xinafoate as maintenance therapy compared with albuterol in patients with asthma.与沙丁胺醇相比,昔萘酸沙美特罗作为哮喘患者的维持治疗药物。
JAMA. 1994 May 11;271(18):1412-6.
6
Anti-inflammatory effects of salmeterol compared with beclomethasone in eosinophilic mild exacerbations of asthma: a randomized, placebo controlled trial.沙美特罗与倍氯米松在嗜酸性粒细胞性轻度哮喘加重期的抗炎作用比较:一项随机、安慰剂对照试验
Can Respir J. 1998 Jul-Aug;5(4):261-8. doi: 10.1155/1998/868379.
7
Efficacy, safety, and impact on quality of life of salmeterol in patients with moderate persistent asthma.沙美特罗对中度持续性哮喘患者的疗效、安全性及生活质量的影响
Am J Manag Care. 1998 Nov;4(11):1579-87.
8
Comparison of addition of salmeterol to inhaled steroids with doubling of the dose of inhaled steroids.沙美特罗添加至吸入性糖皮质激素与吸入性糖皮质激素剂量加倍的比较。
Am J Respir Crit Care Med. 1996 May;153(5):1481-8. doi: 10.1164/ajrccm.153.5.8630590.
9
Salmeterol. An appraisal of its quality-of-life benefits and potential pharmacoeconomic positioning in asthma.沙美特罗。对其在哮喘中改善生活质量的益处及潜在药物经济学定位的评估。
Pharmacoeconomics. 1995 Jun;7(6):562-74. doi: 10.2165/00019053-199507060-00010.
10
Tolerability of a salmeterol xinafoate/fluticasone propionate hydrofluoroalkane metered-dose inhaler in adolescent and adult patients with persistent asthma: a 52-week, open-label, stratified, parallel-group, multicenter study.丙酸氟替卡松/昔萘酸沙美特罗氢氟烷计量吸入器在青少年和成年持续性哮喘患者中的耐受性:一项为期52周的开放标签、分层、平行组、多中心研究。
Clin Ther. 2007 Jul;29(7):1390-402. doi: 10.1016/j.clinthera.2007.07.021.

引用本文的文献

1
Can pharmacists influence the health-related quality of life of patients with asthma?: The New Zealand Pharmaceutical Care experience.药剂师能否影响哮喘患者与健康相关的生活质量?:新西兰药学服务的经验。
J Sci Res Med Sci. 2001 Oct;3(2):69-75.
2
Addition of long-acting beta2-agonists to inhaled corticosteroids versus same dose inhaled corticosteroids for chronic asthma in adults and children.长效β2受体激动剂与相同剂量吸入性糖皮质激素联合应用于成人及儿童慢性哮喘的疗效比较
Cochrane Database Syst Rev. 2010 May 12(5):CD005535. doi: 10.1002/14651858.CD005535.pub2.
3
Addition of long-acting beta2-agonists to inhaled steroids versus higher dose inhaled steroids in adults and children with persistent asthma.在患有持续性哮喘的成人和儿童中,长效β2受体激动剂与高剂量吸入性类固醇联合使用与单纯使用高剂量吸入性类固醇的比较。
Cochrane Database Syst Rev. 2010 Apr 14(4):CD005533. doi: 10.1002/14651858.CD005533.pub2.
4
Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults and children.对于未使用过类固醇的成人和儿童持续性哮喘,吸入长效β2受体激动剂联合吸入性类固醇作为一线治疗方案。
Cochrane Database Syst Rev. 2009 Oct 7;2009(4):CD005307. doi: 10.1002/14651858.CD005307.pub2.
5
Long-acting beta2-agonists as an inhaled corticosteroid-sparing agent for chronic asthma in adults and children.长效β2受体激动剂作为成人和儿童慢性哮喘的吸入性糖皮质激素节省剂。
Cochrane Database Syst Rev. 2005 Oct 19;2005(4):CD005076. doi: 10.1002/14651858.CD005076.pub2.
6
Best practice in symptom assessment: a review.症状评估的最佳实践:综述
Gut. 2004 May;53 Suppl 4(Suppl 4):iv49-54. doi: 10.1136/gut.2003.034355.
7
Measuring health-related quality of life in patients with chronic obstructive pulmonary disease in a routine hospital setting: feasibility and perceived value.在常规医院环境中测量慢性阻塞性肺疾病患者的健康相关生活质量:可行性与感知价值
Health Qual Life Outcomes. 2003 Apr 11;1:5. doi: 10.1186/1477-7525-1-5.
8
Use of ultramolecular potencies of allergen to treat asthmatic people allergic to house dust mite: double blind randomised controlled clinical trial.使用超分子效力的过敏原治疗对屋尘螨过敏的哮喘患者:双盲随机对照临床试验。
BMJ. 2002 Mar 2;324(7336):520. doi: 10.1136/bmj.324.7336.520.
9
Cost-effectiveness analysis of formoterol versus salmeterol in patients with asthma.福莫特罗与沙美特罗治疗哮喘患者的成本效益分析。
Pharmacoeconomics. 1998 Dec;14(6):671-84. doi: 10.2165/00019053-199814060-00007.
10
Quality-of-life measures as providers of information on value-for-money of health interventions. Comparison and recommendations for practice.作为健康干预性价比信息提供者的生活质量衡量指标。实践中的比较与建议。
Pharmacoeconomics. 1997 Jan;11(1):19-31. doi: 10.2165/00019053-199711010-00004.

本文引用的文献

1
Diary keeping in asthma: comparison of written and electronic methods.哮喘患者的日记记录:书面记录与电子记录方法的比较
BMJ. 1993 Feb 20;306(6876):487-9. doi: 10.1136/bmj.306.6876.487.
2
Accuracy of perception of severity of asthma: patients treated in general practice.哮喘严重程度感知的准确性:全科医疗中接受治疗的患者
BMJ. 1993 Aug 14;307(6901):422-4. doi: 10.1136/bmj.307.6901.422.
3
Sensitivity of quality of life domains and constructs to longitudinal change in a clinical trial comparing salmeterol with placebo in asthmatics.在一项比较沙美特罗与安慰剂治疗哮喘患者的临床试验中,生活质量领域和结构对纵向变化的敏感性。
Qual Life Res. 1994 Apr;3(2):121-6. doi: 10.1007/BF00435255.
4
Added salmeterol versus higher-dose corticosteroid in asthma patients with symptoms on existing inhaled corticosteroid. Allen & Hanburys Limited UK Study Group.在使用现有吸入性糖皮质激素仍有症状的哮喘患者中,加用沙美特罗与高剂量糖皮质激素的比较。英国艾伦汉伯里有限公司研究小组。
Lancet. 1994 Jul 23;344(8917):219-24. doi: 10.1016/s0140-6736(94)92996-3.
5
Do asthmatic patients correctly record home spirometry measurements?哮喘患者是否正确记录家庭肺功能测量值?
BMJ. 1994 Dec 17;309(6969):1618. doi: 10.1136/bmj.309.6969.1618.
6
A methodological framework for assessing health indices.一种评估健康指数的方法框架。
J Chronic Dis. 1985;38(1):27-36. doi: 10.1016/0021-9681(85)90005-0.
7
Problems of recall and misclassification with checklist methods of measuring stressful life events.使用清单法测量应激性生活事件时的回忆问题和错误分类问题。
Health Psychol. 1991;10(1):62-74. doi: 10.1037//0278-6133.10.1.62.
8
A scale for assessing quality of life in adult asthma sufferers.一种用于评估成年哮喘患者生活质量的量表。
J Psychosom Res. 1991;35(1):99-110. doi: 10.1016/0022-3999(91)90011-c.
9
A scale for the measurement of quality of life in adults with asthma.一种用于测量成年哮喘患者生活质量的量表。
J Clin Epidemiol. 1992 May;45(5):461-72. doi: 10.1016/0895-4356(92)90095-5.
10
Evaluation of impairment of health related quality of life in asthma: development of a questionnaire for use in clinical trials.哮喘患者健康相关生活质量损害的评估:用于临床试验的问卷编制
Thorax. 1992 Feb;47(2):76-83. doi: 10.1136/thx.47.2.76.

一项临床试验中哮喘生活质量日记的验证

Validation of an asthma quality of life diary in a clinical trial.

作者信息

Hyland M E, Crocker G R

机构信息

Department of Psychology, University of Plymouth, UK.

出版信息

Thorax. 1995 Jul;50(7):724-30. doi: 10.1136/thx.50.7.724.

DOI:10.1136/thx.50.7.724
PMID:7570405
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC474643/
Abstract

BACKGROUND

Quality of life (QOL) is commonly measured in asthma clinical trials by a questionnaire given before and after treatment. A structured asthma QOL daily diary provides more restricted information but on a daily basis. The validity and use of such a QOL diary was examined in a clinical trial in which two asthma treatments were compared.

METHODS

The effects of low dose inhaled steroid (400 micrograms beclomethasone dipropionate, BDP) combined with the long acting beta 2 agonist salmeterol (100 micrograms) (n = 220) was compared with high dose inhaled steroid (1000 micrograms BDP) (n = 206) in asthmatic outpatients in a double blind, parallel group study. Outcome measures consisted of a combined diary for peak expiratory flow (PEF) rate, symptoms, and problems, and an asthma-specific QOL questionnaire, the Living with Asthma Questionnaire.

RESULTS

The QOL diary correlated with the QOL questionnaire for both cross sectional and longitudinal assessments. Cross sectional correlations with PEF were higher for the QOL questionnaire than the QOL diary, but longitudinal correlations with PEF were higher for the diary than the questionnaire. Treatment with low dose steroid/salmeterol compared with high dose steroid produced better lung function, better QOL as measured by diary, and reduced night time wakenings, but treatment differences were not obtained with the QOL questionnaire nor for daytime symptoms. Diary assessed QOL was a better predictor of low PEF than diary assessed symptoms. Compliance with diary completion was good but there were floor or ceiling effects in the QOL diary records of about 25% of patients.

CONCLUSIONS

Structured QOL diaries are valid instruments that appear to be more responsive to longitudinal change in clinical trials than a QOL questionnaire, but QOL questionnaires provide a more sensitive cross sectional measure of disease severity. Floor and ceiling effects are found in some patients' QOL diaries which limit their usefulness. QOL diary problem events occur during the troughs of a peak flow graph, while symptoms are more widely distributed with respect to peak flow.

摘要

背景

在哮喘临床试验中,生活质量(QOL)通常通过治疗前后发放的问卷进行测量。结构化的哮喘QOL每日日记提供的信息更为有限,但却是基于每日情况。在一项比较两种哮喘治疗方法的临床试验中,对这种QOL日记的有效性及应用进行了研究。

方法

在一项双盲、平行组研究中,将低剂量吸入性类固醇(400微克二丙酸倍氯米松,BDP)联合长效β2激动剂沙美特罗(100微克)(n = 220)的效果与高剂量吸入性类固醇(1000微克BDP)(n = 206)在哮喘门诊患者中的效果进行了比较。结果指标包括一份综合日记,记录呼气峰值流速(PEF)、症状和问题,以及一份哮喘特异性QOL问卷,即《哮喘生活问卷》。

结果

无论是横断面评估还是纵向评估,QOL日记与QOL问卷均具有相关性。QOL问卷与PEF的横断面相关性高于QOL日记,但日记与PEF的纵向相关性高于问卷。与高剂量类固醇治疗相比,低剂量类固醇/沙美特罗治疗产生了更好的肺功能、日记所测量的更好的QOL,并减少了夜间觉醒,但在QOL问卷方面以及日间症状方面未观察到治疗差异。日记评估的QOL比日记评估的症状更能预测低PEF。日记填写的依从性良好,但约25%患者的QOL日记记录存在地板效应或天花板效应。

结论

结构化的QOL日记是有效的工具,在临床试验中似乎比QOL问卷对纵向变化更敏感,但QOL问卷能提供更敏感的疾病严重程度横断面测量。在一些患者的QOL日记中发现了地板效应和天花板效应,这限制了它们的实用性。QOL日记中的问题事件发生在峰值流速图的低谷期,而症状在峰值流速方面分布更广泛。